BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality. However, much of the disease burden remains undiagnosed. AIM: To compare the yield and cost effectiveness of two COPD case-finding approaches in primary care. DESIGN AND SETTING: Pilot randomised controlled trial in two general practices in the West Midlands, UK. METHOD: A total of 1634 ever-smokers aged 35-79 years with no history of COPD or asthma were randomised into either a 'targeted' or 'opportunistic' case-finding arm. Respiratory questionnaires were posted to patients in the 'targeted' arm and provided to patients in the 'opportunistic' arm at routine GP appointments. Those reporting at least one chronic respiratory symptom were invited for spirometry. COPD was defined as pre-bronchodilator forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC)<0.7 and FEV1<80% of predicted. Primary outcomes were the difference in the proportion of patients diagnosed with COPD and the cost per case detected. RESULTS: Twenty-six per cent (212/815) in the 'targeted' and 13.6% (111/819) in the 'opportunistic' arm responded to the questionnaire and 78.3% (166/212) and 73.0% (81/111), respectively, reported symptoms; 1.2% (10/815) and 0.7% (6/819) of patients in the 'targeted' and 'opportunistic' arms were diagnosed with COPD (difference in proportions = 0.5% [95% confidence interval {CI} = -0.5% to 3.08%]). Over a 12-month period, the 'opportunistic' case-finding yield could be improved to 1.95% (95% CI = 1.0% to 2.9%). The cost-per case detected was £424.56 in the 'targeted' and £242.20 in the 'opportunistic' arm. CONCLUSION: Opportunistic case finding may be more effective and cost effective than targeting patients with a postal questionnaire alone. A larger randomised controlled trial with adequate sample size is required to test this.
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality. However, much of the disease burden remains undiagnosed. AIM: To compare the yield and cost effectiveness of two COPD case-finding approaches in primary care. DESIGN AND SETTING: Pilot randomised controlled trial in two general practices in the West Midlands, UK. METHOD: A total of 1634 ever-smokers aged 35-79 years with no history of COPD or asthma were randomised into either a 'targeted' or 'opportunistic' case-finding arm. Respiratory questionnaires were posted to patients in the 'targeted' arm and provided to patients in the 'opportunistic' arm at routine GP appointments. Those reporting at least one chronic respiratory symptom were invited for spirometry. COPD was defined as pre-bronchodilator forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC)<0.7 and FEV1<80% of predicted. Primary outcomes were the difference in the proportion of patients diagnosed with COPD and the cost per case detected. RESULTS: Twenty-six per cent (212/815) in the 'targeted' and 13.6% (111/819) in the 'opportunistic' arm responded to the questionnaire and 78.3% (166/212) and 73.0% (81/111), respectively, reported symptoms; 1.2% (10/815) and 0.7% (6/819) of patients in the 'targeted' and 'opportunistic' arms were diagnosed with COPD (difference in proportions = 0.5% [95% confidence interval {CI} = -0.5% to 3.08%]). Over a 12-month period, the 'opportunistic' case-finding yield could be improved to 1.95% (95% CI = 1.0% to 2.9%). The cost-per case detected was £424.56 in the 'targeted' and £242.20 in the 'opportunistic' arm. CONCLUSION: Opportunistic case finding may be more effective and cost effective than targeting patients with a postal questionnaire alone. A larger randomised controlled trial with adequate sample size is required to test this.
Authors: Constant P van Schayck; Ronald J Halbert; Robert J Nordyke; Sharon Isonaka; Jaman Maroni; Dmitry Nonikov Journal: Respirology Date: 2005-06 Impact factor: 6.424
Authors: Kylie Hill; Roger S Goldstein; Gordon H Guyatt; Maria Blouin; Wan C Tan; Lori L Davis; Diane M Heels-Ansdell; Marko Erak; Pauline J Bragaglia; Itamar E Tamari; Richard Hodder; Matthew B Stanbrook Journal: CMAJ Date: 2010-04-06 Impact factor: 8.262
Authors: Nicola A Hanania; David M Mannino; Barbara P Yawn; Douglas W Mapel; Fernando J Martinez; James F Donohue; Mark Kosinski; Regina Rendas-Baum; Matthew Mintz; Steven Samuels; Priti Jhingran; Anand A Dalal Journal: Respir Med Date: 2010-03-11 Impact factor: 3.415
Authors: Peter Frith; Alan Crockett; Justin Beilby; David Marshall; Robyn Attewell; Avnesh Ratnanesan; Guy Gavagna Journal: Prim Care Respir J Date: 2011-06
Authors: Vicente Gil-Guillén; Domingo Orozco-Beltrán; Concepcion V Carratala Munuera; Carlos Plaza-Sirvent; Patricia Lorca-Amorrich; Adriana López-Pineda; María P Vela-Troncoso; Juan J Soler; Manuel Yarza-Cañellas; Antonio Fernández; Luis Rosado-Bretón; Carmen Olivares-Bautista; Alejandro Muñoz-Fernández Journal: BMC Public Health Date: 2011-05-31 Impact factor: 3.295
Authors: Hannah Whittaker; Annalisa Rubino; Hana Müllerová; Tamsin Morris; Precil Varghese; Yang Xu; Enrico De Nigris; Jennifer K Quint Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-03-03
Authors: Shamil Mm Haroon; Rachel E Jordan; Joanne O'Beirne-Elliman; Peymane Adab Journal: NPJ Prim Care Respir Med Date: 2015-08-27 Impact factor: 2.871
Authors: Rachel E Jordan; Peymané Adab; Sue Jowett; Jen L Marsh; Richard D Riley; Alexandra Enocson; Martin R Miller; Brendan G Cooper; Alice M Turner; Jon G Ayres; Kar Keung Cheng; Kate Jolly; Robert A Stockley; Sheila Greenfield; Stanley Siebert; Amanda Daley; David A Fitzmaurice Journal: BMC Pulm Med Date: 2014-10-04 Impact factor: 3.317